PT4101454T - Composições para utilização no tratamento da hipertensão - Google Patents
Composições para utilização no tratamento da hipertensãoInfo
- Publication number
- PT4101454T PT4101454T PT221881725T PT22188172T PT4101454T PT 4101454 T PT4101454 T PT 4101454T PT 221881725 T PT221881725 T PT 221881725T PT 22188172 T PT22188172 T PT 22188172T PT 4101454 T PT4101454 T PT 4101454T
- Authority
- PT
- Portugal
- Prior art keywords
- hypertension
- compositions
- treatment
- Prior art date
Links
- 206010020772 Hypertension Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762450324P | 2017-01-25 | 2017-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT4101454T true PT4101454T (pt) | 2024-06-17 |
Family
ID=62979058
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT221881725T PT4101454T (pt) | 2017-01-25 | 2018-01-23 | Composições para utilização no tratamento da hipertensão |
PT187453626T PT3573620T (pt) | 2017-01-25 | 2018-01-23 | Composições para o tratamento da hipertensão |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT187453626T PT3573620T (pt) | 2017-01-25 | 2018-01-23 | Composições para o tratamento da hipertensão |
Country Status (22)
Country | Link |
---|---|
US (5) | US10322117B2 (pt) |
EP (3) | EP4101454B1 (pt) |
JP (2) | JP2020506180A (pt) |
KR (2) | KR20240096848A (pt) |
CN (2) | CN110545819A (pt) |
AU (2) | AU2018213147B2 (pt) |
BR (1) | BR112019015368A2 (pt) |
CA (1) | CA3051374A1 (pt) |
DK (2) | DK4101454T3 (pt) |
ES (2) | ES2940316T3 (pt) |
FI (2) | FI4101454T3 (pt) |
HR (2) | HRP20240701T1 (pt) |
HU (1) | HUE061444T2 (pt) |
LT (2) | LT4101454T (pt) |
MX (2) | MX2019008813A (pt) |
PL (2) | PL3573620T3 (pt) |
PT (2) | PT4101454T (pt) |
RS (2) | RS65701B1 (pt) |
RU (1) | RU2019126749A (pt) |
SI (1) | SI3573620T1 (pt) |
TW (3) | TW201831204A (pt) |
WO (1) | WO2018138578A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10369156B2 (en) | 2016-11-15 | 2019-08-06 | The George Institute for Global Health | Compositions for the treatment of hypertension |
RU2019126749A (ru) | 2017-01-25 | 2021-02-26 | Зэ Джордж Инститьют Фор Глобал Хелс | Композиции для лечения гипертензии |
JP2021536443A (ja) * | 2018-08-25 | 2021-12-27 | シーアールディー ファーマシューティカルズ インコーポレイティド | 高血圧治療をサーカディアンリズムと同期させる |
CN111789843A (zh) * | 2019-04-08 | 2020-10-20 | 深圳奥萨医药有限公司 | 含氨氯地平、氯噻酮和阿米洛利的药物组合物 |
CN113616651B (zh) * | 2020-05-08 | 2023-12-29 | 深圳奥萨制药有限公司 | 一种复方降压药物组合物及其应用 |
US11730706B1 (en) * | 2022-07-07 | 2023-08-22 | Antecip Bioventures Ii Llc | Treatment of depression in certain patient populations |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT199800126A (es) | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
ES2263604T5 (es) | 2000-04-10 | 2017-02-07 | Nicholas John Wald | Formulación para la Prevención de Enfermedad Cardiovascular |
GB2361185A (en) | 2000-04-10 | 2001-10-17 | Nicholas J Wald | Pharmaceutical formulation for the prevention of cardiovascular disease |
EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
US20050187262A1 (en) * | 2004-01-12 | 2005-08-25 | Grogan Donna R. | Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use |
EP1734958A1 (en) | 2004-04-06 | 2006-12-27 | Merck & Co., Inc. | Methods for the treatment of hypertension |
KR100582347B1 (ko) | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
US20070196510A1 (en) | 2006-02-17 | 2007-08-23 | Gerber Michael J | Method for treating resistant hypertension |
ES2388555T3 (es) | 2006-03-16 | 2012-10-16 | Metabolic Solutions Development Company Llc | Análogos de tiazolidindiona |
WO2007146900A2 (en) | 2006-06-15 | 2007-12-21 | Gilead Colorado, Inc. | Antihypertensive therapy method |
EP2190433A2 (en) | 2007-08-22 | 2010-06-02 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
KR20090057538A (ko) * | 2007-12-03 | 2009-06-08 | 박사룡 | 안지오텐신 투 안타고니스트, 칼슘 안타고니스트 및이뇨제를 함유하는 고혈압 치료제 조성물 |
CN101450211A (zh) * | 2007-12-07 | 2009-06-10 | 上海艾力斯医药科技有限公司 | 复方降压制剂 |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
EP3563842A1 (en) | 2009-04-29 | 2019-11-06 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
CN101966187A (zh) * | 2009-07-14 | 2011-02-09 | 邬林祥 | 一种治疗高血压含氨氯地平和厄贝沙坦的复方制剂 |
CN101618215A (zh) | 2009-08-16 | 2010-01-06 | 王丽燕 | 含钙拮抗剂、aⅱ受体拮抗剂和他汀类药的药物组合物 |
WO2011149438A1 (en) * | 2010-05-28 | 2011-12-01 | Mahmut Bilgic | Combination of antihypertensive agents |
CN101966190A (zh) * | 2010-07-17 | 2011-02-09 | 邬林祥 | 一种治疗高血压含氨氯地平和依普罗沙坦的复方制剂 |
CN102225203A (zh) * | 2011-06-29 | 2011-10-26 | 北京阜康仁生物制药科技有限公司 | 一种用于降低血压的药用组合物 |
CN102327272B (zh) | 2011-07-14 | 2013-08-14 | 海南锦瑞制药股份有限公司 | 一种口服固体药用组合物及其制备方法 |
US10918612B2 (en) * | 2013-01-22 | 2021-02-16 | Markus Zwickl | Combinations with 2-aminoethanesulfonic acid |
US9839644B2 (en) * | 2014-09-09 | 2017-12-12 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
CZ2015687A3 (cs) | 2015-10-02 | 2017-04-12 | Zentiva, K.S. | Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu |
CN106310278A (zh) * | 2016-08-01 | 2017-01-11 | 深圳奥萨制药有限公司 | 一种含叶酸的多联降压药物组合物 |
US10369156B2 (en) | 2016-11-15 | 2019-08-06 | The George Institute for Global Health | Compositions for the treatment of hypertension |
RU2019126749A (ru) | 2017-01-25 | 2021-02-26 | Зэ Джордж Инститьют Фор Глобал Хелс | Композиции для лечения гипертензии |
CA3107616A1 (en) | 2018-07-26 | 2020-01-30 | The George Institute for Global Health | Compositions for the treatment of hypertension |
-
2018
- 2018-01-23 RU RU2019126749A patent/RU2019126749A/ru unknown
- 2018-01-23 FI FIEP22188172.5T patent/FI4101454T3/fi active
- 2018-01-23 PL PL18745362.6T patent/PL3573620T3/pl unknown
- 2018-01-23 LT LTEP22188172.5T patent/LT4101454T/lt unknown
- 2018-01-23 PT PT221881725T patent/PT4101454T/pt unknown
- 2018-01-23 CN CN201880021071.6A patent/CN110545819A/zh active Pending
- 2018-01-23 AU AU2018213147A patent/AU2018213147B2/en active Active
- 2018-01-23 EP EP22188172.5A patent/EP4101454B1/en active Active
- 2018-01-23 WO PCT/IB2018/000083 patent/WO2018138578A1/en unknown
- 2018-01-23 RS RS20240644A patent/RS65701B1/sr unknown
- 2018-01-23 ES ES18745362T patent/ES2940316T3/es active Active
- 2018-01-23 JP JP2019539974A patent/JP2020506180A/ja active Pending
- 2018-01-23 SI SI201830873T patent/SI3573620T1/sl unknown
- 2018-01-23 KR KR1020247019312A patent/KR20240096848A/ko not_active Application Discontinuation
- 2018-01-23 PT PT187453626T patent/PT3573620T/pt unknown
- 2018-01-23 HR HRP20240701TT patent/HRP20240701T1/hr unknown
- 2018-01-23 PL PL22188172.5T patent/PL4101454T3/pl unknown
- 2018-01-23 DK DK22188172.5T patent/DK4101454T3/da active
- 2018-01-23 CN CN202310463571.8A patent/CN116327958A/zh active Pending
- 2018-01-23 KR KR1020197024682A patent/KR20190127691A/ko active Application Filing
- 2018-01-23 DK DK18745362.6T patent/DK3573620T3/da active
- 2018-01-23 EP EP24164449.1A patent/EP4374915A3/en active Pending
- 2018-01-23 BR BR112019015368-3A patent/BR112019015368A2/pt active IP Right Grant
- 2018-01-23 LT LTEPPCT/IB2018/000083T patent/LT3573620T/lt unknown
- 2018-01-23 RS RS20230204A patent/RS64042B1/sr unknown
- 2018-01-23 HU HUE18745362A patent/HUE061444T2/hu unknown
- 2018-01-23 HR HRP20230267TT patent/HRP20230267T1/hr unknown
- 2018-01-23 EP EP18745362.6A patent/EP3573620B1/en active Active
- 2018-01-23 CA CA3051374A patent/CA3051374A1/en active Pending
- 2018-01-23 MX MX2019008813A patent/MX2019008813A/es unknown
- 2018-01-23 FI FIEP18745362.6T patent/FI3573620T3/fi active
- 2018-01-23 ES ES22188172T patent/ES2981657T3/es active Active
- 2018-01-25 TW TW107102631A patent/TW201831204A/zh unknown
- 2018-01-25 TW TW112142923A patent/TW202421198A/zh unknown
- 2018-01-25 TW TW109105655A patent/TWI825279B/zh active
- 2018-03-13 US US15/919,923 patent/US10322117B2/en active Active
-
2019
- 2019-04-24 US US16/393,774 patent/US10799487B2/en active Active
- 2019-07-24 MX MX2023004366A patent/MX2023004366A/es unknown
-
2020
- 2020-09-08 US US17/014,358 patent/US11478462B2/en active Active
-
2022
- 2022-09-16 US US17/932,982 patent/US12102623B2/en active Active
- 2022-12-14 JP JP2022199757A patent/JP2023063282A/ja active Pending
-
2023
- 2023-08-08 US US18/446,268 patent/US20230381161A1/en active Pending
- 2023-11-27 AU AU2023274064A patent/AU2023274064A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL4101454T3 (pl) | Kompozycje do stosowania w leczeniu nadciśnienia | |
ZA201902781B (en) | Compositions and methods for the treatment of xerostomia | |
TWI799397B (zh) | 用於治療高血壓之組合物 | |
IL244622A0 (en) | Preparations for the treatment of hypertension and/or fibrosis | |
IL244621A (en) | Preparations for the treatment of hypertension and / or fibrosis | |
IL251345B (en) | Preparations for use in the treatment of peri-implantitis | |
HK1225994A1 (zh) | 用於治療過敏性病症的組合物 | |
SI3373922T1 (sl) | Sestavki in postopki za uporabo pri zdravljenju homocistinurije | |
GB2581876B (en) | Compositions for use in the treatment of endometrial disorder | |
HK1255695A1 (zh) | 用於治療眼瞼下垂的組合物和方法 | |
IL265242B (en) | Compounds for the treatment of hypertension and/or fibrosis | |
RS65009B1 (sr) | Sastav za upotrebu u lečenju crevnih promena | |
IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
ZA202006591B (en) | Compositions for the treatment of hypertension | |
SG11201706369PA (en) | Compositions and methods for the treatment of mucositis | |
GB201513543D0 (en) | Compositions for use in the treatment of diabetes | |
GB201718975D0 (en) | Novel compositions having use in therapy | |
PL3273997T3 (pl) | Kompozycja do leczenia nieżytu nosa |